Trial intelligence / Profile preview

Dexmedetomidine added to bupivacaine for erector spinae plane block after modified radical mastectomy

PACTR202307885435649Phase 0Completed

Sponsor
Ain Shams University Faculty of Medicine
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 0, randomised trial in postoperative pain comparing Dexmedetomidine + bupivacaine ESP block with Bupivacaine ESP block control (2 arms). Primary endpoints: Time to first rescue analgesia request, Pain score and 1 more. Started Jul 2023; status: completed.

02

Drugs

dexmedetomidinebupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on PACTR202307885435649.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202307885435649.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call